Cannabis adulterated with the synthetic cannabinoid receptor agonist MDMB-4en-PINACA and the role of European drug checking services.
- DOI
- 10.1016/j.drugpo.2021.103493
- Published
- 2021-10-20
- Container
- Int J Drug Policy
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.drugpo.2021.103493,
title = {Cannabis adulterated with the synthetic cannabinoid receptor agonist MDMB-4en-PINACA and the role of European drug checking services.},
author = {Oomen PE and Schori D and Tögel-Lins K and Acreman D and Chenorhokian S and Luf A and Karden A and Paulos C and Fornero E and Gerace E and Koning RPJ and Galindo L and Smit-Rigter LA and Measham F and Ventura M.},
year = {2022},
journal = {Int J Drug Policy},
doi = {10.1016/j.drugpo.2021.103493},
url = {https://doi.org/10.1016/j.drugpo.2021.103493}
}RIS
TY - JOUR TI - Cannabis adulterated with the synthetic cannabinoid receptor agonist MDMB-4en-PINACA and the role of European drug checking services. AU - Oomen PE AU - Schori D AU - Tögel-Lins K AU - Acreman D AU - Chenorhokian S AU - Luf A AU - Karden A AU - Paulos C AU - Fornero E AU - Gerace E AU - Koning RPJ AU - Galindo L AU - Smit-Rigter LA AU - Measham F AU - Ventura M. PY - 2022 JO - Int J Drug Policy DO - 10.1016/j.drugpo.2021.103493 UR - https://doi.org/10.1016/j.drugpo.2021.103493 ER -
APA
PE, O., D, S., K, T., D, A., S, C., A, L., A, K., C, P., E, F., E, G., RPJ, K., L, G., LA, S., F, M., & M., V. (2022). Cannabis adulterated with the synthetic cannabinoid receptor agonist MDMB-4en-PINACA and the role of European drug checking services.. Int J Drug Policy. https://doi.org/10.1016/j.drugpo.2021.103493
Source records
- europe-pmc · retrieved 2026-09-27T05:10:24.150Z